C12N 2710/10351
Methods of production or purification of viral material
C12N2710/10351 (Methods of production or purification of viral material) appears on 268 US grants and 406 published applications in this corpus.
Search patents in C12N- Granted patents
- 268
- Published applications
- 406
- Assignees
- 175
- Inventors
- 583
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 4 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 11 | 0 |
| 2001 | 12 | 7 |
| 2002 | 17 | 32 |
| 2003 | 14 | 40 |
| 2004 | 13 | 16 |
| 2005 | 13 | 28 |
| 2006 | 16 | 14 |
| 2007 | 8 | 17 |
| 2008 | 11 | 18 |
| 2009 | 8 | 9 |
| 2010 | 5 | 12 |
| 2011 | 5 | 11 |
| 2012 | 10 | 10 |
| 2013 | 3 | 7 |
| 2014 | 4 | 10 |
| 2015 | 8 | 6 |
| 2016 | 8 | 11 |
| 2017 | 8 | 10 |
| 2018 | 2 | 15 |
| 2019 | 10 | 14 |
| 2020 | 14 | 20 |
| 2021 | 4 | 10 |
| 2022 | 7 | 24 |
| 2023 | 11 | 23 |
| 2024 | 10 | 20 |
| 2025 | 17 | 18 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Rescue of recombinant adenoviruses by CRISPR/Cas-mediated in vivo terminal resolution25 Aug 2026US 12,716,064 B2Albert-Ludwigs-Universität Freiburg
- Recombinant adenovirus expressing African swine fever virus EP153R-EP402R protein and construction method thereof5 May 2026US 12,618,083 B2Institute of Animal Sciences of Chinese Academy of Agricultural Sciences
- Method for producing a virus and a harvesting solution composition2 Dec 2025US 12,486,487 B2Hangzhou Converd Co., Ltd.
- Rapid verification of virus particle production for a personalized vaccine2 Dec 2025US 12,487,241 B2NantBio, Inc.
- Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine18 Nov 2025US 12,472,145 B2Board of Regents, The University of Texas System
- Tet-r expression cassettes and cell lines16 Jul 2026US 2026/0201417 A1Cevec Pharmaceuticals GmbH
- Culture medium composition9 Jul 2026US 2026/0193602 A1Ajinomoto Co., Inc.
- Methods of Targeting Mutant Cells28 May 2026US 2026/0144897 A1President and Fellows of Harvard College
- Stabilization of virus-based therapeutic agent14 May 2026US 2026/0130983 A1Elarex Inc.
- Method for the purification of recombinant adenovirus vectors25 Dec 2025US 2025/0388873 A1Ferring International Center S.A.
Most cited
By later US patents
- Packaging systems for human recombinant adenovirus to be used in gene therapy267US 5,994,128 AIntrogene B.V. · 1999
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus184US 5,994,106 AGenVec, Inc. · 1999
- Packaging systems for human recombinant adenovirus to be used in gene therapy178US 6,033,908 AIntrogene B.V. · 2000
- Complementary adenoviral systems and cell lines125US 5,851,806 AGenVec, Inc. · 1998